2025-10-31

Q3 2025 Results

Financial data not available in provided content

2025-07-31

Q2 2025 Results

2025-04-30

Q1 2025 Results

Financial data not available in provided content

2025-02-25

FY 2024 Results

Financial metrics not clearly extractable from this XBRL format

2025-11-26

Executive Officer Designations

4 officers removed from executive designation effective Dec 31, 2025

2025-10-16

Legal Opinion Filing

Legal opinion filed for Series P Notes and Series A Notes under existing S-3 shelf registration

2025-10-15

Q3 Earnings

Net income $8.5B, EPS $1.06

2025-09-15

Co-Presidents Appointed

Dean Athanasia & James DeMare named Co-Presidents, Borthwick promoted to EVP

2025-09-12

Executive Appointments - Co-Presidents Named

Dean Athanasia and James DeMare appointed Co-Presidents, Alastair Borthwick named EVP

2025-07-24

Preferred Stock Offering

2.5M depositary shares, 6.25% Series UU preferred stock, $25K liquidation preference

2025-07-23

Stock Buyback & Dividend

$40B buyback program, $0.28 quarterly dividend

2025-07-16

Q2 2025 Earnings

Net income $7.1B, EPS $0.89

2025-07-01

Dividend Increase & CCAR Results

Dividend up to $0.28/share, CET1 ratio 11.8%

2025-04-29

Preferred Stock Offering

3M depositary shares, Series OO 6.625% preferred stock

2025-04-24

Annual Shareholder Meeting

Equity plan amended: +100M shares, director comp capped at $1M annually

2025-04-15

Q1 2025 Earnings

Net income $7.4B, EPS $0.90

2025-02-28

Chief Accounting Officer Change

Johnbull Okpara appointed CAO, $600K salary + $5.4M incentive

2025-02-07

CEO Compensation Approved

Moynihan 2024 total comp $35M vs $29M in 2023

2025-01-29

Director Appointed

Maria N. Martinez appointed to Board and committees

2025-01-16

Q4 2024 Earnings

Q4 net income $6.7B, EPS $0.82; FY net income $27.1B, EPS $3.21